ITC Commentary on the Prediction of Digoxin Clinical Drug–Drug Interactions from In Vitro Transporter Assays

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|96|3|298-301

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.96, Iss.3, 2014-09, pp. : 298-301

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transporter‐Mediated Drug–Drug Interactions Involving OATP Substrates: Predictions Based on In Vitro Inhibition Studies

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 91, Iss. 6, 2012-06 ,pp. : 1053-1064

John Wiley & Sons Inc

Access to resources Recommend Favorite

In Vitro Prediction of Clinical Drug Interactions With CYP3A Substrates: We Are Not There Yet

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 95, Iss. 2, 2014-02 ,pp. : 133-135

John Wiley & Sons Inc

Access to resources Recommend Favorite

Human hepatocyte assessment of imatinib drug–drug interactions – complexities in clinical translation

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 5, 2015-11 ,pp. : 1097-1108

John Wiley & Sons Inc

Access to resources Recommend Favorite

Computational Prospecting for Drug–Transporter Interactions

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 94, Iss. 1, 2013-07 ,pp. : 30-32

John Wiley & Sons Inc

Access to resources Recommend Favorite

Using Positron Emission Tomography to Study Transporter‐Mediated Drug–Drug Interactions in Tissues

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 2, 2014-08 ,pp. : 206-213

John Wiley & Sons Inc

Access to resources Recommend Favorite